Joining the previously disparate, Expressionist analyzes and integrates transcriptomics, proteomics, metabolomics and conventional toxicology data in a single software platform.

With the analysis of phenotypic data – clinical chemistry, histopathology, physiology, and stressor data - Genedata Expressionist takes a true cross-omics approach to better biomarkers.

Cross-omics delivers more informative biomarkers than the single technology approach: The prediction of a disease state or mode-of-action of a compound becomes more precise with fewer items needed.

Reliable high-quality biomarkers can benefit pharmaceutical R&D in many ways: informed drug candidate selection, prediction of a compound’s toxicity and mode-of-action, pharmaco-dynamics evaluation, patient stratification, personalized medicine, clinical trial diagnosis etc.

The Expressionist Integrated analysis application note focuses on:

• Combining omics and conventional toxicology data
• Integrating across omics for reliable prediction results
• Validating results using multiple technology platforms
• Analyzing microarrays across versions and generations

Click for a list of supported technologies.

Visit our promotion material page for module brochures, posters and publications.

To find out more about Expressionist, demos and pricing, please follow the navigation menus on the right hand side or contact us by using this webform.